Abstract
This section summarises the diagnostic and therapeutic steps discussed in the previous sections. The goal is to outline the most important steps in the management of patients with NSTE-ACS. In each individual patient, decision making should take into account the patient's history (e.g. age, comorbidities), clinical presentation (e.g. ongoing myocardial ischaemia, haemodynamic or electrical instability), findings obtained during the initial assessment (i.e. ECG, cardiac troponin), timing and expected risk-benefit ratio of available therapies (i.e. pharmacological, invasive assessment, revascularization).
Original language | English |
---|---|
Pages (from-to) | 267-315 |
Number of pages | 49 |
Journal | European Heart Journal |
Volume | 37 |
Issue number | 3 |
DOIs | |
Publication status | Published - 14 Jan 2016 |
Keywords
- Acute cardiac care
- Acute coronary syndromes
- Angioplasty
- Anticoagulation
- Apixaban
- Aspirin
- Atherothrombosis
- Beta-blockers
- Bivalirudin
- Bypass surgery
- Cangrelor
- Chest pain unit
- Clopidogrel
- Dabigatran
- Diabetes
- Early invasive strategy
- Enoxaparin
- European society of cardiology
- Fondaparinux
- Glycoprotein IIb/IIIa inhibitors
- Guidelines
- Heparin
- High-sensitivity troponin
- Myocardial ischaemia
- Nitrates
- Non-ST-elevation myocardial infarction
- Platelet inhibition
- Prasugrel
- Recommendations
- Revascularization
- Rhythm monitoring
- Rivaroxaban
- Statin
- Stent
- Ticagrelor
- Unstable angina
- Vorapaxar
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine